Korro Bio, Inc. 是一家生物制药公司,基于RNA编辑技术发现、开发并商业化基因药物,用于治疗罕见及高发疾病。公司总部位于马萨诸塞州剑桥。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$129.2万
2025-09-30
$109万
营业支出
2026-06-30
$2011万
2026-03-31
$2043.6万
2025-12-31
$1652.6万
2025-09-30
$2032.7万
净利润
2026-06-30
-$1891.6万
2026-03-31
-$1962.5万
2025-12-31
-$5004.2万
2025-09-30
-$1806.1万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
-3.87K%
2025-09-30
-1.65K%
每股收益
2026-06-30
$-1.07
2026-03-31
$-1.69
2025-12-31
$-1.65
2025-09-30
$-1.92
息税折旧摊销前利润
2026-06-30
-$1974.7万
2026-03-31
-$2005.6万
2025-12-31
-$1523.4万
2025-09-30
-$1688.2万
有效税率
2026-06-30
-0.57%
2026-03-31
-0.48%
2025-12-31
-1.28%
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$129.2万
$109万
营业支出
$2011万
$2043.6万
$1652.6万
$2032.7万
净利润
-$1891.6万
-$1962.5万
-$5004.2万
-$1806.1万
净利润率
--
--
-3.87K%
-1.65K%
每股收益
$-1.07
$-1.69
$-1.65
$-1.92
息税折旧摊销前利润
-$1974.7万
-$2005.6万
-$1523.4万
-$1688.2万
有效税率
-0.57%
-0.48%
-1.28%
--
常见问题
KRRO stock represents shares of a publicly traded company. Because the company's specific name and business focus have not been provided, the most accurate way to identify what KRRO stock represents is to check the ticker details, company profile, and exchange listing displayed on the KRRO stock page. That page typically shows the company's sector, headquarters, and principal business activities, giving investors a clearer picture of the underlying business before they research further.
The current price of KRRO stock changes throughout each trading session as buyers and sellers submit orders. Because the latest quote depends on real-time market activity, it should be read directly from the KRRO stock page rather than from a static description. That page typically displays the most recent trade price, along with related data such as daily change and trading volume, so investors can see how KRRO is trading at that moment.
Valuation of KRRO stock usually involves comparing its market price with financial measures such as earnings, sales, book value, and cash flow. Common tools include the price-to-earnings ratio, price-to-sales ratio, and enterprise value multiples, which are most useful when compared with peers in the same industry and with KRRO's own historical averages. Since these figures depend on current market data and reported financials, investors should use the valuation metrics shown on the KRRO stock page.
KRRO stock may be available for trading in pre-market and after-hours sessions, depending on whether it is listed on a major U.S. exchange and whether brokers support extended-hours trading. These sessions usually have lower liquidity, wider bid-ask spreads, and higher price volatility than regular trading hours. Whether KRRO specifically can be traded outside regular hours depends on the exchange and the individual broker's rules, so investors should confirm availability before placing such orders.
Useful metrics for KRRO often include revenue growth, gross and operating margins, net income, earnings per share, free cash flow, debt levels, and return on equity. These measures help investors judge growth, profitability, financial strength, and cash generation. Comparing KRRO's metrics across several quarters and against industry peers can reveal trends that a single figure may hide. The exact values should be taken from KRRO's latest quarterly and annual reports rather than estimated.
Risks for KRRO depend on its industry, business model, financial condition, and market environment. Common risks can include competition, customer concentration, regulatory changes, supply-chain disruptions, debt obligations, and the possibility of weaker-than-expected revenue or earnings. Broader market declines, rising interest rates, and shifts in investor sentiment can also affect KRRO's share price. Reviewing the risk factors in KRRO's annual report and recent filings can help investors understand company-specific exposures.